News in the Life Sciences Industry

ABBOTT PARK, Ill., Sept. 21, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2020 financial results on Wednesday, Oct. 21, 2020, before the market opens.

ABBOTT PARK, Ill., Sept. 21, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark for its fourth-generation MitraClip(TM) Transcatheter Mitral Valve Repair System, the leading minimally invasive mitral valve repair device in the world. Known as MitraClip G4, the device... Read more ››

DÜSSELDORF, Germany, Sept. 18, 2020 /PRNewswire/ -- FUJIFILM Europe GmbH announced today that CAD EYE™ is now commercially available in Europe. CAD EYE™ is a new software with two functions for colon polyp detection and characterisation utilising Artificial Intelligence (AI) based on deep... Read more ››

COPENHAGEN, Denmark, Sept. 17, 2020 /PRNewswire/ -- IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology, today announced a late-breaking, oral presentation of best-in-class efficacy data in... Read more ››

ABBOTT PARK, Ill., Sept. 17, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) is introducing the world's first glucose sport biosensor,(i) Libre Sense Glucose Sport Biosensor, which is designed for athletes to continuously measure glucose to better understand the correlation between their glucose levels... Read more ››

HEIDENHEIM, Germany, Sept. 17, 2020 /PRNewswire/ -- Together with the "World Day for Patient Safety" of the World Health Organization (WHO), today HARTMANN is launching its initiative to reduce the risk of healthcare-related infection - Mission: Infection Prevention (M: IP). The company is... Read more ››

Supply Agreement will continue into 2021

BAD HOMBURG, Germany, Sept. 17, 2020 /PRNewswire/ -- MYR Pharmaceuticals, a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D, is pleased to announce that HEPCLUDEX(®) (bulevirtide) has successfully launched... Read more ››

OSAKA, Japan and FORT WORTH, Texas, Sept. 16, 2020 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (hereinafter "Santen") and Eyevance Holdings LLC announced that Santen Holdings U.S. Inc., a wholly-owned subsidiary of Santen, and Eyevance Holdings LLC entered into a share purchase agreement... Read more ››

MUNICH, VIENNA and DENVER, Sept. 16, 2020 /PRNewswire/ -- TLL The Longevity Labs GmbH (Longevity Labs+), an Austrian-based life sciences company, and its wholly-owned, US subsidiary, Longevity Labs Inc., are proud to announce their award for "The Most Innovative OTC-Product" at the German 2020... Read more ››

WOBURN, Mass., Sept. 15, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer... Read more ››